Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology.
Authors:
- H. ChableHCH. Chable
- S. PaulhacSPS. Paulhac
- Y. AubardYAY. Aubard
Open Access
- 1 September 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 14 (9) , 2236-2241
Abstract
To investigate follicular effects of recombinant human follicle stimulating hormone (rhFSH) induction on women with polycystic ovary syndrome (PCOS), steroid content was compared in mature follicles obtained using a long luteinizing hormone-releasing hormone agonist plus rhFSH or human menopausal gonadotrophin (HMG) in PCOS women and controls participating in an in-vitro fertilization programme. Follicular fluids (144 samples) were collected at oocyte retrieval by individual selective aspiration. Oocyte maturity and fecundability were assessed. Plasma and intrafollicular 17β-oestradiol, progesterone, testosterone concentrations were assayed individually. No significant difference was seen in oocyte maturity and fecundability between PCOS and controls following rhFSH, or between PCOS rhFSH and HMG group. 17β-oestradiol, testosterone and progesterone concentrations were lower in PCOS follicular fluid following rhFSH than HMG but the difference was not significant. Progesterone concentration, 17β-oestradiol/progesterone, 17β-oestradiol/testosterone were significantly different between the two induction groups, for PCOS fertilized oocyte follicles (P = 0.01, P < 0.05 and P < 0.05 respectively). Steroidogenic enzymatic activity seems to be regulated in healthy follicular cells in PCOS as well as in normal patients upon ovarian induction. Following rhFSH, higher PCOS follicular progesterone concentrations leading to a theoretically increased fecundability could suggest that recombinant FSH is a better inducer which needs to be confirmed.Keywords
This publication has 24 references indexed in Scilit:
- Polycystic ovary syndrome: anomalies in progesterone productionHuman Reproduction, 1998
- Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniquesHuman Reproduction, 1997
- Colour Doppler assessment of ascendent uterine artery perfusion in an in-vitro fertilization-embryo transfer programme after pituitary desensitization and ovarian stimulation with human recombinant follicle stimulating hormoneHuman Reproduction, 1997
- Detection of immunoreactive interleukin-11 in human follicular fluid: correlations with ovarian steroid, insulin-like growth factor I levels, and follicular maturityFertility and Sterility, 1997
- Increase in androgen:estrogen ratio specifically during low-dose follicle-stimulating hormone therapy for polycystic ovary syndromeFertility and Sterility, 1995
- Endocrinology of the ovary*Human Reproduction, 1994
- Granulosa cells of polycystic ovaries: are they normal or abnormal?Human Reproduction, 1992
- Correlation between follicular fluid content and the results of in vitro fertilization and embryo transfer. I. Sex steroidsFertility and Sterility, 1989
- POLYCYSTIC OVARY SYNDROME: A CHANGING PERSPECTIVEClinical Endocrinology, 1989
- SUCCESSFUL FERTILISATION OF HUMAN OOCYTES IN VITRO: CONCENTRATION OF ESTRADIOL-17S, PROGESTERONE AND ANDROSTENEDIONE IN THE ANTRAL FLUID OF DONOR FOLLICLES.11The Journal of Clinical Endocrinology & Metabolism, 1982